Skip Header

 

1 - 25 of 59 results for author:"Davis K."Drop in Literature Citations

Customize display Download...

Page of 3 | Next »

Racial differences in paraoxonase-1 (PON1): a factor in the health of southerners?

Davis K.A., Crow J.A., Chambers H.W., Meek E.C., Chambers J.E.

Environ. Health Perspect. 117:1226-1231(2009) · Mapped (3)

C/EBPalpha and the corepressors CtBP1 and CtBP2 regulate repression of select visceral white adipose genes during induction of the brown phenotype in white adipocytes by peroxisome proliferator-activated receptor gamma agonists.

Vernochet C., Peres S.B., Davis K.E., McDonald M.E., Qiang L., Wang H., Scherer P.E., Farmer S.R.

Mol. Cell. Biol. 29:4714-4728(2009) · Mapped (16)

Genetic identity, biological phenotype, and evolutionary pathways of transmitted/founder viruses in acute and early HIV-1 infection.

Salazar-Gonzalez J.F., Salazar M.G., Keele B.F., Learn G.H., Giorgi E.E., Li H., Decker J.M., Wang S., Baalwa J., Kraus M.H. et al.

J. Exp. Med. 206:1273-1289(2009) · UniProtKB (817)

ODC1 is a critical determinant of MYCN oncogenesis and a therapeutic target in neuroblastoma.

Hogarty M.D., Norris M.D., Davis K., Liu X., Evageliou N.F., Hayes C.S., Pawel B., Guo R., Zhao H., Sekyere E. et al.

Cancer Res. 68:9735-9745(2008) · Mapped (11)

Compost and compost water extract-induced systemic acquired resistance in cucumber and Arabidopsis.

Zhang W., Han D.Y., Dick W.A., Davis K.R., Hoitink H.A.

Phytopathology 88:450-455(1998) · Mapped (1)

Programmed cell death of primordial germ cells in Drosophila is regulated by p53 and the Outsiders monocarboxylate transporter.

Yamada Y., Davis K.D., Coffman C.R.

Development 135:207-216(2008) · Mapped (9)

Substrate specificities and activities of AZAP family Arf GAPs in vivo.

Cuthbert E.J., Davis K.K., Casanova J.E.

Am. J. Physiol., Cell Physiol. 294:C263-70(2008) · Mapped (14)

CNTNAP2 gene dosage variation is associated with schizophrenia and epilepsy.

Friedman J.I., Vrijenhoek T., Markx S., Janssen I.M., van der Vliet W.A., Faas B.H., Knoers N.V., Cahn W., Kahn R.S., Edelmann L. et al.

Mol. Psychiatry 13:261-266(2008) · Mapped (20)

Molecular dissection of NRG1-ERBB4 signaling implicates PTPRZ1 as a potential schizophrenia susceptibility gene.

Buxbaum J.D., Georgieva L., Young J.J., Plescia C., Kajiwara Y., Jiang Y., Moskvina V., Norton N., Peirce T., Williams H. et al.

Mol. Psychiatry 13:162-172(2008) · Mapped (2)

Role of glutamate decarboxylase (GAD) isoform, GAD65, in GABA synthesis and transport into synaptic vesicles-Evidence from GAD65-knockout mice studies.

Wu H., Jin Y., Buddhala C., Osterhaus G., Cohen E., Jin H., Wei J., Davis K., Obata K., Wu J.Y.

Brain Res. 1154:80-83(2007) · Mapped (5)

Predictive modeling of plant messenger RNA polyadenylation sites.

Ji G., Zheng J., Shen Y., Wu X., Jiang R., Lin Y., Loke J.C., Davis K.M., Reese G.J., Li Q.Q.

BMC Bioinformatics 8:43-43(2007) · Mapped (3)

ARAP2 effects on the actin cytoskeleton are dependent on Arf6-specific GTPase-activating-protein activity and binding to RhoA-GTP.

Yoon H.Y., Miura K., Cuthbert E.J., Davis K.K., Ahvazi B., Casanova J.E., Randazzo P.A.

J. Cell. Sci. 119:4650-4666(2006) · Mapped (12)

The human homolog of the QKI gene affected in the severe dysmyelination "quaking" mouse phenotype: downregulated in multiple brain regions in schizophrenia.

Haroutunian V., Katsel P., Dracheva S., Davis K.L.

Am J Psychiatry 163:1834-1837(2006) · Mapped (3)

Convergent evidence that oligodendrocyte lineage transcription factor 2 (OLIG2) and interacting genes influence susceptibility to schizophrenia.

Georgieva L., Moskvina V., Peirce T., Norton N., Bray N.J., Jones L., Holmans P., Macgregor S., Zammit S., Wilkinson J. et al.

Proc. Natl. Acad. Sci. U.S.A. 103:12469-12474(2006) · Mapped (14)

Risperidone irreversibly binds to and inactivates the h5-HT7 serotonin receptor.

Smith C., Rahman T., Toohey N., Mazurkiewicz J., Herrick-Davis K., Teitler M.

Mol. Pharmacol. 70:1264-1270(2006) · Mapped (3)

Serotonin 5-HT2C receptor homodimer biogenesis in the endoplasmic reticulum: real-time visualization with confocal fluorescence resonance energy transfer.

Herrick-Davis K., Weaver B.A., Grinde E., Mazurkiewicz J.E.

J. Biol. Chem. 281:27109-27116(2006) · Mapped (2)

Inhibition of serotonin 5-hydroxytryptamine2c receptor function through heterodimerization: receptor dimers bind two molecules of ligand and one G-protein.

Herrick-Davis K., Grinde E., Harrigan T.J., Mazurkiewicz J.E.

J. Biol. Chem. 280:40144-40151(2005) · Mapped (2)

The role of selection in the evolution of human mitochondrial genomes.

Kivisild T., Shen P., Wall D.P., Do B., Sung R., Davis K., Passarino G., Underhill P.A., Scharfe C., Torroni A. et al.

Genetics 172:373-387(2006) · UniProtKB (332)

Metabotropic glutamate receptor protein expression in the prefrontal cortex and striatum in schizophrenia.

Gupta D.S., McCullumsmith R.E., Beneyto M., Haroutunian V., Davis K.L., Meador-Woodruff J.H.

Synapse 57:123-131(2005) · Mapped (2)

Augmentation of cocaine hyperactivity in rats by systemic ghrelin.

Wellman P.J., Davis K.W., Nation J.R.

Regul. Pept. 125:151-154(2005) · Mapped (1)

Biochemical and biophysical characterization of serotonin 5-HT2C receptor homodimers on the plasma membrane of living cells.

Herrick-Davis K., Grinde E., Mazurkiewicz J.E.

Biochemistry 43:13963-13971(2004) · Mapped (2)

The forkhead transcription factor FoxC2 inhibits white adipocyte differentiation.

Davis K.E., Moldes M., Farmer S.R.

J. Biol. Chem. 279:42453-42461(2004) · Mapped (2)

Role of residues 143 and 278 of the human nuclear Vitamin D receptor in the full-length and Delta165-215 deletion mutant.

Acevedo A., Stoynova L., Davis K., Solorzano R., Collins E.D.

J. Steroid Biochem. Mol. Biol. 89-90:83-87(2004) · Mapped (5)

Protein phosphorylation of human brain glutamic acid decarboxylase (GAD)65 and GAD67 and its physiological implications.

Wei J., Davis K.M., Wu H., Wu J.Y.

Biochemistry 43:6182-6189(2004) · Mapped (13)

A case-based evaluation of SRD5A1, SRD5A2, AR, and ADRA1A as candidate genes for severity of BPH.

Klotsman M., Weinberg C.R., Davis K., Binnie C.G., Hartmann K.E.

Pharmacogenomics J. 4:251-259(2004) · Mapped (16)

Page of 3 | Next »